Since the approval of four cholinesterase inhibitors in the 1990s and memantine in 2003, there have been no new treatments for Alzheimer’s disease. Against this backdrop, Paul Aisen of the University of California, San Diego, opened the 4th International Conference on Clinical Trials on Alzheimer’s Disease (CTAD) on 3 November ... continue reading
SACRAMENTO, Calif., March 9, 2011 /PRNewswire/ — Anticipating a catastrophic increase in Alzheimer’s disease and related dementias, California leaders have completed the much-anticipated California State Plan for Alzheimer’s disease, a disease estimated to double among Californians by the year 2030. The plan is a 10-year course of action with guiding ... continue reading
Alzheimer’s disease affects twice as many women as it does men, according to a new report that portrays women as being “under siege” by the dreaded condition. Created in conjunction with California first lady Maria Shriver , “The Shriver Report: A Woman’s Nation Takes on Alzheimer’s” shows that two-thirds of ... continue reading
The Shriver Report: A Woman’s Nation Takes on Alzheimer’s is a collaborative research effort by California First Lady Maria Shriver and the Alzheimer’s Association that calls on society and government leaders to address the needs of patients and caregivers, fund more research into treatment for Alzheimer’s and other brain diseases ... continue reading
This week, California’s first lady, Maria Shriver, released The Shriver Report: A Woman’s Nation Takes on Alzheimer’s. It focuses on the impact of the Alzheimer’s epidemic, talks about cutting-edge research, includes personal essays by celebrities, patients, and caregivers, and reveals the results of a large-scale poll on Alzheimer’s.
See the original ... continue reading